DrugPatentWatch Database Preview
Napo Pharms Inc Company Profile
What is the competitive landscape for NAPO PHARMS INC, and what generic alternatives to NAPO PHARMS INC drugs are available?
NAPO PHARMS INC has one approved drug.
There are five US patents protecting NAPO PHARMS INC drugs.
There are thirty-seven patent family members on NAPO PHARMS INC drugs in twenty-two countries.
Summary for Napo Pharms Inc
| International Patents: | 37 |
| US Patents: | 5 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Napo Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Napo Pharms Inc | MYTESI | crofelemer | TABLET, DELAYED RELEASE;ORAL | 202292-001 | Dec 31, 2012 | RX | Yes | Yes | 8,574,634 | ➤ Sign Up | ➤ Sign Up | ||||
| Napo Pharms Inc | MYTESI | crofelemer | TABLET, DELAYED RELEASE;ORAL | 202292-001 | Dec 31, 2012 | RX | Yes | Yes | 8,962,680 | ➤ Sign Up | ➤ Sign Up | ||||
| Napo Pharms Inc | MYTESI | crofelemer | TABLET, DELAYED RELEASE;ORAL | 202292-001 | Dec 31, 2012 | RX | Yes | Yes | 7,323,195 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Napo Pharms Inc | MYTESI | crofelemer | TABLET, DELAYED RELEASE;ORAL | 202292-001 | Dec 31, 2012 | RX | Yes | Yes | 9,585,868 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Napo Pharms Inc | MYTESI | crofelemer | TABLET, DELAYED RELEASE;ORAL | 202292-001 | Dec 31, 2012 | RX | Yes | Yes | 7,341,744 | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Napo Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Napo Pharms Inc | MYTESI | crofelemer | TABLET, DELAYED RELEASE;ORAL | 202292-001 | Dec 31, 2012 | 7,323,195 | ➤ Sign Up |
| Napo Pharms Inc | MYTESI | crofelemer | TABLET, DELAYED RELEASE;ORAL | 202292-001 | Dec 31, 2012 | 8,574,634 | ➤ Sign Up |
| Napo Pharms Inc | MYTESI | crofelemer | TABLET, DELAYED RELEASE;ORAL | 202292-001 | Dec 31, 2012 | 7,341,744 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
International Patents for Napo Pharms Inc Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| New Zealand | 335317 | ➤ Sign Up |
| Denmark | 0935417 | ➤ Sign Up |
| World Intellectual Property Organization (WIPO) | 2012058664 | ➤ Sign Up |
| Germany | 69739394 | ➤ Sign Up |
| South Korea | 100467532 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
